Search Results 2891-2900 of 18211 for rheumatoid arthritis

  1. SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients - Mayo Clinic

    Participation eligibility · Absolute neutrophil count (ANC) < 1000 cells/μl (1.0 x 109/L) (Growth factor cannot be used within the previous 7 days); · Aspartate ...

  2. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    Any factor that, in the opinion of the investigator, would jeopardize the evaluation or safety of the participant or be associated with poor adherence to ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Arthritis, Thyroid cancer, Thyroid nodule, Abscess, Liver problems, Hepatocellular carcinoma, Infection, Bone metastasis, Pneumothorax, Pleural effusion ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Arthritis, Thyroid cancer, Thyroid nodule, Abscess, Liver problems, Hepatocellular carcinoma, Infection, Bone metastasis, Pneumothorax, Pleural effusion ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Arthritis, Thyroid cancer, Thyroid nodule, Abscess, Liver problems, Hepatocellular carcinoma, Infection, Bone metastasis, Pneumothorax, Pleural effusion ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Arthritis, Thyroid cancer, Thyroid nodule, Abscess, Liver problems, Hepatocellular carcinoma, Infection, Bone metastasis, Pneumothorax, Pleural effusion ...

  7. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

    ... arthritis, stroke, and Parkinson's disease. The subject is required to take or has taken immunomodulatory/immunosuppressive agents (except IGIV) that ...

  8. Science Saturday: Identifying best candidates with avascular necrosis for regenerative alternative to hip replacement - Mayo Clinic News Network

    Within seven years, 33% had progressed to total hip replacement for arthritis or worsening necrosis. However, the hip decompression surgery paused bone cell ...

  9. Improve the Patients’ Recovery by Engagement and Partnerships with Family- CaregiveRs to End Delirium - Mayo Clinic

    Participation eligibility · 60 years of age or older. · Have 1 risk factor for delirium (pre-existing cognitive impairment, vision/hearing impairment, identified ...

  10. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    ... factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) rearrangements must have failed or are intolerant to prior treatment with EGFR or ALK ...